Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_33946 | 22 | 0.46 | Mlig455_011628 | Neo: - Age: Down-Down-Up |
SLC22A13 | Mlig455_011628 {REF} {Length: 5855} {Pfam: Sugar (and other) transporter [PF00083.26, score=67.0]; Major Facilitator Superfamily [PF07690.18, score=63.0]} {Human: ENSG00000172940, SLC22A13, solute carrier family 22 member 13, [Score=166, Expect=7e-44]} {Mouse: ENSMUSG00000074028, Slc22a13, solute carrier family 22 (organic cation transporter), member 13, [Score=168, Expect=1e-44]} {Dmel: FBgn0019952, Orct, Organic cation transporter, [Score=157, Expect=6e-41]} {Celegans: WBGene00003842, oct-1, Organic cation transporter 1, [Score=160, Expect=4e-42]} {Smed: dd_Smed_v6_10903_0_1, dd_Smed_v6_10903_0_1, [Score=152, Expect=1e-39]} {RNA1509_32769} {RNA1310_5536} {RNA815_4265} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.179 | 0.828 | 0.99964 | 1.00000 | |
RegionR2 | -0.161 | 0.828 | 0.83948 | 1.00000 | |
RegionR3 | -1.981 | 0.828 | 0.99970 | 1.00000 | |
RegionR4 | 1.653 | 0.828 | 0.32393 | 0.64135 | |
RegionR5 | 0.352 | 0.828 | 0.59771 | 0.95557 | |
RegionR6 | 0.125 | 0.828 | 0.69146 | 1.00000 | |
RegionR7 | 1.348 | 0.828 | 0.42680 | 1.00000 | |
RegionR8 | -1.158 | 0.828 | 0.99971 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.83 | 0.828 | 0.99997 | 1.00000 | |
RegenerationR2 | 1.424 | 0.828 | 0.30348 | 0.74469 | |
RegenerationR3 | 1.56 | 0.828 | 0.36567 | 0.78038 | |
RegenerationR4 | -0.704 | 0.828 | 0.70450 | 0.95542 | |
RegenerationR5 | -0.921 | 0.828 | 0.60072 | 0.91031 | |
RegenerationR6 | -3.286 | 0.828 | 0.10308 | 0.39765 | |
RegenerationBL | -2.856 | 0.828 | 0.99972 | 1.00000 | |
RegenerationTP | 0.312 | 0.828 | 0.84148 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_33946 | 22 | 0.46 | Mlig455_011628 | Neo: - Age: Down-Down-Up |
SLC22A13 | 3 | - | - | 1.000 | - | 1.000 | 1.000 | Mlig455_011628 {REF} {Length: 5855} {Pfam: Sugar (and other) transporter [PF00083.26, score=67.0]; Major Facilitator Superfamily [PF07690.18, score=63.0]} {Human: ENSG00000172940, SLC22A13, solute carrier family 22 member 13, [Score=166, Expect=7e-44]} {Mouse: ENSMUSG00000074028, Slc22a13, solute carrier family 22 (organic cation transporter), member 13, [Score=168, Expect=1e-44]} {Dmel: FBgn0019952, Orct, Organic cation transporter, [Score=157, Expect=6e-41]} {Celegans: WBGene00003842, oct-1, Organic cation transporter 1, [Score=160, Expect=4e-42]} {Smed: dd_Smed_v6_10903_0_1, dd_Smed_v6_10903_0_1, [Score=152, Expect=1e-39]} {RNA1509_32769} {RNA1310_5536} {RNA815_4265} |
2. | MligTC455_51559 | 43 | 0.89 | Mlig455_002923, Mlig455_002941 | Neo: - Age: - Region-enriched R2: 6.806/0.01463 |
2.613 | - | - | 0.738 | - | 0.966 | 0.909 | Mlig455_002923 {REF} {Length: 1008} {RNA1310_77227} {RNA815_43894} Mlig455_002941 {REF} {Length: 897} {RNA1310_88681} {RNA815_43894} |
|
3. | MligTC455_28711 | 44 | 0.91 | Mlig455_022368, Mlig455_022378, Mlig455_022455 | Neo: - Age: - |
KREMEN2 | 1.95 | - | - | - | - | 0.975 | 0.975 | Mlig455_022368 {REF} {Length: 1557} {Pfam: WSC domain [PF01822.21, score=45.5]; PAN domain [PF00024.28, score=22.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=46.2, Expect=1e-05]} {RNA1310_35396.1} {RNA815_23500} Mlig455_022378 {REF} {Length: 1444} {Pfam: WSC domain [PF01822.21, score=37.3]; PAN domain [PF00024.28, score=21.3]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.1, Expect=1e-05]} {RNA1310_89673} {RNA815_59435} Mlig455_022455 {REF} {Length: 1345} {Pfam: WSC domain [PF01822.21, score=51.4]; PAN domain [PF00024.28, score=23.1]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=7e-07]} {RNA1310_89673} {RNA815_23500} |
4. | MligTC455_12545 | 37 | 0.76 | Mlig455_069121 | Neo: - Age: - |
1.946 | - | - | - | - | 0.980 | 0.966 | Mlig455_069121 {REF} {Length: 1966} {RNA1310_47776.1} {RNA815_35125} | |
5. | MligTC455_23543 | 79 | 1.65 | Mlig455_021851 | Neo: - Age: - Region-enriched R2: 5.153/0.00077 |
MAP3K19 | 1.936 | - | - | - | - | 0.988 | 0.948 | Mlig455_021851 {REF} {Length: 7454} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=226.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=217.3]; Ankyrin repeats (3 copies) [PF12796.9, score=113.8]; Ankyrin repeats (many copies) [PF13637.8, score=82.7]; Ankyrin repeats (many copies) [PF13857.8, score=77.3]; F5/8 type C domain [PF00754.27, score=56.3]; Ankyrin repeat [PF00023.32, score=55.9]; Ankyrin repeat [PF13606.8, score=49.9]; ABC1 atypical kinase-like domain [PF03109.18, score=28.7]} {Human: ENSG00000176601, MAP3K19, mitogen-activated protein kinase kinase kinase 19, [Score=159, Expect=2e-40]} {Mouse: ENSMUSG00000051590, Map3k19, mitogen-activated protein kinase kinase kinase 19, [Score=164, Expect=3e-42]} {Dmel: FBgn0266465, GckIII, Germinal centre kinase III, [Score=146, Expect=1e-35]} {Celegans: WBGene00001526, gck-1, Germinal center kinase 1, [Score=139, Expect=2e-33]} {Smed: dd_Smed_v6_10339_0_1, dd_Smed_v6_10339_0_1, [Score=153, Expect=2e-37]} {RNA1509_46581} {RNA1310_9191} {RNA815_12161} |
6. | MligTC455_53467 | 98 | 2.05 | Mlig455_032611 | Neo: - Age: Down-Down-Up Region-enriched R8: 4.858/0.00151 |
1.921 | - | - | - | - | 0.944 | 0.977 | Mlig455_032611 {REF} {Length: 2547} {Pfam: Carbohydrate binding domain (family 19) [PF03427.15, score=19.0]} {RNA1509_1990} {RNA1310_48790} {RNA815_9320.1} | |
7. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
1.92 | - | - | - | - | 0.963 | 0.957 | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
8. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
1.919 | - | - | - | - | 0.946 | 0.973 | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
9. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
1.915 | - | - | - | - | 0.963 | 0.952 | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
10. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
1.909 | - | - | - | - | 0.947 | 0.962 | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
11. | MligTC455_39464 | 45 | 0.94 | Mlig455_031874 | Neo: - Age: Up-Down-Down |
1.909 | - | - | - | - | 0.947 | 0.962 | Mlig455_031874 {REF} {Length: 2026} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=140.6]} {RNA1310_22174} {RNA815_24783} | |
12. | MligTC455_02856 | 53 | 1.1 | Mlig455_000236, Mlig455_058498 | Neo: - Age: Down-Up-Up |
B3GNT4, B3GNT6 | 1.907 | - | - | - | - | 0.972 | 0.935 | Mlig455_000236 {REF} {Length: 881} {Pfam: Galactosyltransferase [PF01762.23, score=37.0]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=54.7, Expect=2e-08]} {Mouse: ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=50.8, Expect=2e-07]} {Dmel: FBgn0035558, CG11357, [Score=56.2, Expect=3e-09]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=67.8, Expect=1e-13]} {RNA1310_46446} {RNA815_58184} Mlig455_058498 {REF} {Length: 1681} {Pfam: Galactosyltransferase [PF01762.23, score=143.0]; Fringe-like [PF02434.18, score=22.3]} {Human: ENSG00000198488, B3GNT6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6, [Score=123, Expect=6e-31]; ENSG00000172318, B3GALT1, beta-1,3-galactosyltransferase 1, [Score=119, Expect=8e-30]} {Mouse: ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=123, Expect=6e-31]; ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=119, Expect=5e-30]} {Dmel: FBgn0035558, CG11357, [Score=157, Expect=2e-43]} {Celegans: WBGene00011659, T09E11.10, Hexosyltransferase, [Score=58.2, Expect=3e-09]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=201, Expect=3e-61]} {RNA1509_17403} {RNA1310_46446} {RNA815_28728} |
13. | MligTC455_45861 | 18 | 0.38 | Mlig455_034439 | Neo: - Age: - |
1.899 | - | - | - | - | 0.957 | 0.942 | Mlig455_034439 {REF} {Length: 1135} {RNA1310_86023} | |
14. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.899 | - | - | - | - | 0.958 | 0.941 | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
15. | MligTC455_03382 | 210 | 4.37 | Mlig455_057035 | Neo: - Age: - Region-enriched R2: 3.628/0.00113 |
PDE1C | 1.895 | - | - | - | - | 0.988 | 0.907 | Mlig455_057035 {REF} {Length: 2458} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=275.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=94.2]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [RH, Score=538, Expect=0.0]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=482, Expect=2e-164]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=613, Expect=0.0]} {RNA1509_46084} {RNA1310_8143.1} {RNA815_6002} |
16. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 1.894 | - | - | - | - | 0.952 | 0.942 | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
17. | MligTC455_40874 | 65 | 1.34 | Mlig455_051048 | Neo: - Age: - |
ASIC5 | 1.893 | - | - | - | - | 0.937 | 0.956 | Mlig455_051048 {REF} {Length: 2313} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=194.4]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=54.3, Expect=4e-07]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=64.7, Expect=1e-10]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [RH, Score=491, Expect=1e-167]} {RNA1509_56048} {RNA1310_34335} {RNA815_62672} |
18. | MligTC455_13846 | 32 | 0.67 | Mlig455_013761 | Neo: - Age: - |
CALM2 | 1.892 | - | - | - | - | 0.966 | 0.926 | Mlig455_013761 {REF} {Length: 941} {Pfam: EF hand [PF00036.34, score=94.2]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13499.8, score=83.6]; EF hand [PF13202.8, score=77.1]; EF-hand domain pair [PF13833.8, score=42.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.3]; EF-hand domain [PF14658.8, score=23.8]; Ca2+ insensitive EF hand [PF08726.12, score=21.5]; Caleosin related protein [PF05042.15, score=21.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=60.1, Expect=1e-11]; ENSG00000160014, CALM3, calmodulin 3, [Score=60.1, Expect=1e-11]; ENSG00000198668, CALM1, calmodulin 1, [Score=60.1, Expect=1e-11]; ENSG00000178363, CALML3, calmodulin like 3, [Score=59.3, Expect=2e-11]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=60.5, Expect=1e-11]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=60.1, Expect=8e-12]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=60.1, Expect=8e-12]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=59.7, Expect=1e-11]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=60.8, Expect=3e-12]} {Celegans: WBGene00019352, K03A1.4, [Score=70.9, Expect=8e-16]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=97.4, Expect=1e-26]} {RNA1310_47452} {RNA815_31258} |
19. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 1.892 | - | - | - | - | 0.952 | 0.940 | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
20. | MligTC455_34749 | 10 | 0.21 | Mlig455_026129 | Neo: - Age: Up-Down-Down |
RASGRF2 | 1.891 | - | - | - | - | 0.938 | 0.953 | Mlig455_026129 {REF} {Length: 5810} {Pfam: RasGEF domain [PF00617.21, score=176.1]; RhoGEF domain [PF00621.22, score=96.8]; RasGEF N-terminal motif [PF00618.22, score=65.5]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=21.2]} {Human: ENSG00000113319, RASGRF2, Ras protein specific guanine nucleotide releasing factor 2, [Score=506, Expect=3e-158]} {Mouse: ENSMUSG00000032356, Rasgrf1, RAS protein-specific guanine nucleotide-releasing factor 1, [Score=484, Expect=2e-149]} {Dmel: FBgn0001965, Sos, Son of sevenless, [Score=136, Expect=6e-32]} {Celegans: WBGene00004947, sos-1, Son of sevenless homolog, [Score=105, Expect=1e-22]} {Smed: dd_Smed_v6_18313_0_2, dd_Smed_v6_18313_0_2, [Score=747, Expect=0.0]} {RNA1509_15697} {RNA1310_18289} {RNA815_21605.1} |
21. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
1.888 | - | - | - | - | 0.957 | 0.931 | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
22. | MligTC455_31663 | 23 | 0.48 | Mlig455_013845 | Neo: - Age: - |
1.887 | - | - | - | - | 0.971 | 0.916 | Mlig455_013845 {REF} {Length: 1056} {RNA1310_32319} {RNA815_18072} | |
23. | MligTC455_49285 | 164 | 3.41 | Mlig455_004486, Mlig455_037380 | Neo: - Age: - Region-specific R2: 6.095 Region-enriched R2: 5.942/0.00244 |
LEF1 | 1.887 | - | - | - | - | 0.957 | 0.930 | Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} |
24. | MligTC455_51807 | 28 | 0.59 | Mlig455_046394 | Neo: - Age: - |
GPSM2 | 1.887 | - | - | - | - | 0.959 | 0.928 | Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322} |
25. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.886 | - | - | - | - | 0.985 | 0.901 | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
26. | MligTC455_19585 | 83 | 1.72 | Mlig455_041765 | Neo: - |
PCDH11X | 1.886 | - | - | - | - | 0.981 | 0.905 | Mlig455_041765 {REF} {Length: 5069} {Pfam: Cadherin domain [PF00028.19, score=307.9]; Cadherin-like [PF08266.14, score=46.0]; Cadherin-like [PF16184.7, score=24.6]} {Human: ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=294, Expect=4e-84]; ENSG00000184226, PCDH9, protocadherin 9, [Score=293, Expect=4e-84]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=290, Expect=9e-83]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [RH, Score=301, Expect=7e-86]} {Dmel: FBgn0001075, ft, fat, [Score=242, Expect=9e-66]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=206, Expect=4e-54]} {Smed: dd_Smed_v6_15181_0_1, dd_Smed_v6_15181_0_1, [RH, Score=275, Expect=2e-78]} {RNA1509_46943} {RNA1310_9721, RNA1509_46943} {RNA1509_46943, RNA815_23754} |
27. | MligTC455_42427 | 30 | 0.63 | Mlig455_040552, Mlig455_062085 | Neo: - Age: - |
ANGPT1, ANGPTL2 | 1.886 | - | - | - | - | 0.961 | 0.925 | Mlig455_040552 {REF} {Length: 1447} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=132.5]} {Human: ENSG00000154188, ANGPT1, angiopoietin 1, [Score=108, Expect=3e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=108, Expect=3e-26]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=108, Expect=4e-27]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=104, Expect=8e-25]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=110, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=2e-26]; ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=108, Expect=3e-26]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=105, Expect=3e-25]} {Dmel: FBgn0030163, CG1791, [Score=94.4, Expect=3e-23]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=3e-20]} {RNA1310_118725} Mlig455_062085 {REF} {Length: 1538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.9]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=108, Expect=4e-26]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=108, Expect=5e-27]; ENSG00000154188, ANGPT1, angiopoietin 1, [Score=107, Expect=7e-26]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=105, Expect=2e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=2e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=110, Expect=5e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=2e-26]; ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=107, Expect=7e-26]} {Dmel: FBgn0030163, CG1791, [Score=93.6, Expect=5e-23]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=89.4, Expect=5e-20]} {RNA1310_118725} |
28. | MligTC455_50729 | 93 | 1.94 | Mlig455_000196, Mlig455_067698 | Neo: - Age: logFC(26M/2M)=0.692 |
1.886 | - | - | - | - | 0.925 | 0.961 | Mlig455_000196 {REF} {Length: 3755} {RNA1310_22511} {RNA815_9029} Mlig455_067698 {REF} {Length: 3647} {RNA1310_22511} {RNA815_9029} |
|
29. | MligTC455_18185 | 11 | 0.23 | Mlig455_044004 | Neo: - Age: - |
STK32B | 1.885 | - | - | - | - | 0.984 | 0.901 | Mlig455_044004 {REF} {Length: 1959} {Pfam: Protein kinase domain [PF00069.27, score=179.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=89.1]; Kinase-like [PF14531.8, score=35.6]; Phosphotransferase enzyme family [PF01636.25, score=18.5]} {Human: ENSG00000152953, STK32B, serine/threonine kinase 32B, [RH, Score=394, Expect=5e-135]; ENSG00000169302, STK32A, serine/threonine kinase 32A, [RH, Score=382, Expect=2e-130]} {Mouse: ENSMUSG00000039954, Stk32a, serine/threonine kinase 32A, [RH, Score=402, Expect=2e-138]} {Dmel: FBgn0052944, CG32944, [Score=348, Expect=4e-117]} {Celegans: WBGene00010838, M03C11.1, [Score=315, Expect=3e-105]} {Smed: dd_Smed_v6_6683_0_1, dd_Smed_v6_6683_0_1, [RH, Score=385, Expect=2e-132]} {RNA1310_81424} {RNA815_49585} |
30. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 1.885 | - | - | - | - | 0.984 | 0.901 | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
31. | MligTC455_50794 | 32 | 0.67 | Mlig455_026944, Mlig455_027032, Mlig455_027095 | Neo: - Age: - |
1.885 | - | - | - | - | 0.984 | 0.901 | Mlig455_026944 {REF} {Length: 1102} {Pfam: Lectin C-type domain [PF00059.23, score=41.7]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=73.2, Expect=1e-15]} {RNA1310_33496.1} {RNA815_23317} Mlig455_027032 {REF} {Length: 1107} {Pfam: Lectin C-type domain [PF00059.23, score=45.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=72.4, Expect=3e-15]} {RNA1310_33496.1} {RNA815_23317} Mlig455_027095 {REF} {Length: 1081} {Pfam: Lectin C-type domain [PF00059.23, score=43.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=66.6, Expect=4e-13]} {RNA1310_33496.1} {RNA815_23317} |
|
32. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
1.884 | - | - | - | - | 0.964 | 0.920 | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
33. | MligTC455_12180 | 107 | 2.23 | Mlig455_038554, Mlig455_052202, Mlig455_053449 | Neo: - Age: logFC(26M/2M)=-0.655 Region-enriched R2: 5.717/0.01573 |
CNGA3 | 1.883 | - | - | - | - | 0.973 | 0.910 | Mlig455_038554 {REF} {Length: 2866} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=75.9]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.6]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=607, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=669, Expect=0.0]} {RNA1310_22950} {RNA815_16119} Mlig455_052202 {REF} {Length: 3203} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=76.1]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.2]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=605, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=667, Expect=0.0]} {RNA1310_22950} {RNA815_16119} Mlig455_053449 {REF} {Length: 991} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=79.9]; Cyclic nucleotide-binding domain [PF00027.31, score=29.1]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=171, Expect=7e-50]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=161, Expect=2e-46]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=155, Expect=4e-44]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=148, Expect=1e-41]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=149, Expect=3e-42]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=155, Expect=8e-45]} {RNA1310_61700} {RNA815_16119} |
34. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
1.883 | - | - | - | - | 0.964 | 0.919 | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
35. | MligTC455_31273 | 40 | 0.83 | Mlig455_017570 | Neo: - Age: - |
JMJD6 | 1.883 | - | - | - | - | 0.961 | 0.922 | Mlig455_017570 {REF} {Length: 2550} {Pfam: Cupin-like domain [PF13621.8, score=84.8]; JmjC domain, hydroxylase [PF02373.24, score=41.9]; Cupin superfamily protein [PF08007.14, score=22.1]} {Human: ENSG00000070495, JMJD6, jumonji domain containing 6, arginine demethylase and lysine hydroxylase, [Score=81.6, Expect=3e-16]} {Mouse: ENSMUSG00000056962, Jmjd6, jumonji domain containing 6, [Score=79.0, Expect=2e-15]} {Dmel: FBgn0038948, PSR, phosphatidylserine receptor, [Score=77.8, Expect=3e-15]} {Celegans: WBGene00004205, psr-1, Bifunctional arginine demethylase and lysyl-hydroxylase psr-1, [Score=88.6, Expect=6e-19]} {Smed: dd_Smed_v6_12267_0_1, dd_Smed_v6_12267_0_1, [RH, Score=327, Expect=7e-108]} {RNA1310_17984} {RNA815_15470} |
36. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 1.883 | - | - | - | - | 0.906 | 0.977 | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
37. | MligTC455_35945 | 130 | 2.71 | Mlig455_065474 | Neo: - Age: Up-Down-Up |
1.879 | - | - | - | - | 0.953 | 0.926 | Mlig455_065474 {REF} {Length: 1654} {RNA1310_22530} {RNA815_54411} | |
38. | MligTC455_00632 | 11 | 0.23 | Mlig455_009708 | Neo: - Age: - |
1.878 | - | - | - | - | 0.978 | 0.900 | Mlig455_009708 {REF} {Length: 1293} {Pfam: Photosystem I protein M (PsaM) [PF07465.15, score=31.8]} | |
39. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 1.878 | - | - | - | - | 0.977 | 0.901 | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
40. | MligTC455_27216 | 56 | 1.18 | Mlig455_022418 | Neo: - |
TRPM3 | 1.877 | - | - | - | - | 0.916 | 0.961 | Mlig455_022418 {REF} {Length: 4794} {Pfam: SLOG in TRPM [PF18139.3, score=136.8]; Ion transport protein [PF00520.33, score=41.0]; SLOG in TRPM, prokaryote [PF18171.3, score=34.2]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=317, Expect=2e-88]; ENSG00000119121, TRPM6, transient receptor potential cation channel subfamily M member 6, [Score=316, Expect=4e-88]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=319, Expect=4e-90]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=309, Expect=7e-88]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=255, Expect=4e-69]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=418, Expect=3e-126]} {RNA1509_17593} {RNA1310_1651, RNA1509_17593} {RNA1509_17593, RNA815_2281} |
41. | MligTC455_50644 | 37 | 0.77 | Mlig455_008094 | Neo: - Age: - |
VSX1 | 1.877 | - | - | - | - | 0.988 | 0.889 | Mlig455_008094 {REF} {Length: 1368} {Pfam: Homeodomain [PF00046.31, score=79.6]} {Human: ENSG00000100987, VSX1, visual system homeobox 1, [RH, Score=197, Expect=4e-60]; ENSG00000119614, VSX2, visual system homeobox 2, [RH, Score=196, Expect=2e-59]} {Mouse: ENSMUSG00000021239, Vsx2, visual system homeobox 2, [RH, Score=196, Expect=6e-60]; ENSMUSG00000033080, Vsx1, visual system homeobox 1, [RH, Score=195, Expect=2e-59]} {Dmel: FBgn0263512, Vsx2, Visual system homeobox 2, [RH, Score=204, Expect=3e-60]} {Celegans: WBGene00000435, ceh-10, Homeobox protein ceh-10, [RH, Score=204, Expect=2e-63]} {Smed: dd_Smed_v6_19286_0_1, dd_Smed_v6_19286_0_1, [RH, Score=211, Expect=2e-66]} {RNA1310_76393} {RNA815_51313} |
42. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
1.876 | - | - | - | - | 0.974 | 0.902 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
43. | MligTC455_23959 | 13 | 0.27 | Mlig455_001171 | Neo: - Age: - |
SLC6A1 | 1.876 | - | - | - | - | 0.956 | 0.920 | Mlig455_001171 {REF} {Length: 2921} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=540.1]} {Human: ENSG00000157103, SLC6A1, solute carrier family 6 member 1, [Score=410, Expect=9e-136]; ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=399, Expect=6e-129]; ENSG00000111181, SLC6A12, solute carrier family 6 member 12, [Score=390, Expect=2e-127]} {Mouse: ENSMUSG00000030310, Slc6a1, solute carrier family 6 (neurotransmitter transporter, GABA), member 1, [Score=410, Expect=8e-136]; ENSMUSG00000030108, Slc6a13, solute carrier family 6 (neurotransmitter transporter, GABA), member 13, [Score=401, Expect=5e-132]; ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=399, Expect=5e-129]; ENSMUSG00000030109, Slc6a12, solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12, [Score=392, Expect=1e-128]} {Dmel: FBgn0034136, DAT, Dopamine transporter, [Score=388, Expect=9e-127]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=373, Expect=3e-121]} {Smed: dd_Smed_v6_8169_0_1, dd_Smed_v6_8169_0_1, [Score=381, Expect=1e-124]} {RNA1310_45592} {RNA815_60993} |
44. | MligTC455_27986 | 21 | 0.43 | Mlig455_006653 | Neo: - Age: - Region-enriched R2: 8.367/0.00454 |
1.876 | - | - | - | - | 0.998 | 0.878 | Mlig455_006653 {REF} {Length: 310} {NoTransDecoderORF} {RNA1310_101700.1} {RNA815_47637} | |
45. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
1.876 | - | - | - | - | 0.983 | 0.893 | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
46. | MligTC455_19454 | 11 | 0.23 | Mlig455_034200 | Neo: - Age: - |
KREMEN1 | 1.875 | - | - | - | - | 0.976 | 0.899 | Mlig455_034200 {REF} {Length: 1253} {Pfam: WSC domain [PF01822.21, score=46.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=57.8, Expect=6e-09]} {RNA1310_36702.1} {RNA815_33128} |
47. | MligTC455_25073 | 1271 | 26.47 | Mlig455_015905 | Neo: - Age: logFC(26M/2M)=-0.947 Region-specific R2: 3.291 Region-enriched R2: 2.110/0.00052 |
PI16 | 1.875 | - | - | - | - | 0.921 | 0.954 | Mlig455_015905 {REF} {Length: 2189} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=7e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.1, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=3e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_36129, RNA1509_46021, RNA1509_5027} {RNA1310_1356.1, RNA1509_36129, RNA1509_46021} {RNA1509_36129, RNA1509_46021, RNA815_4508} |
48. | MligTC455_40522 | 114 | 2.38 | Mlig455_047004, Mlig455_047037 | Neo: - |
ANGPTL3 | 1.874 | - | - | - | - | 0.960 | 0.914 | Mlig455_047004 {REF} {Length: 1341} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=62.5]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=57.0, Expect=8e-09]} {Mouse: ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=52.0, Expect=2e-07]} {Dmel: FBgn0031804, CG9500, [Score=71.2, Expect=2e-14]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=50.1, Expect=6e-07]} {RNA1509_53291} {RNA1310_30694.1} {RNA815_9881} Mlig455_047037 {REF} {Length: 1945} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=60.2]} {Human: ENSG00000132855, ANGPTL3, angiopoietin like 3, [Score=58.9, Expect=8e-09]} {Mouse: ENSMUSG00000022309, Angpt1, angiopoietin 1, [Score=53.1, Expect=4e-07]} {Dmel: FBgn0031804, CG9500, [Score=72.8, Expect=4e-14]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=53.5, Expect=1e-07]} {RNA1509_53291} {RNA1310_30694.1} {RNA815_9881} |
49. | MligTC455_31104 | 22 | 0.46 | Mlig455_040032, Mlig455_070983 | Neo: - Age: - |
SYT17 | 1.873 | - | - | - | - | 0.966 | 0.907 | Mlig455_040032 {REF} {Length: 2712} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} Mlig455_070983 {REF} {Length: 1947} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} |
50. | MligTC455_50931 | 28 | 0.58 | Mlig455_046985, Mlig455_047028 | Neo: - Age: - |
FCN2 | 1.873 | - | - | - | - | 0.972 | 0.901 | Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} |
51. | MligTC455_51759 | 40 | 0.83 | Mlig455_026782 | Neo: - Age: - Region-enriched R4: 4.435/0.02831 |
CNBD2 | 1.873 | - | - | - | - | 0.972 | 0.901 | Mlig455_026782 {REF} {Length: 2590} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=70.9]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=65.1, Expect=2e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=62.4, Expect=1e-09]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0037837, CG14693, [RH, Score=53.9, Expect=3e-07]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=58.9, Expect=8e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=171, Expect=1e-45]} {RNA1310_33768} {RNA815_47620} |
52. | MligTC455_12446 | 8 | 0.17 | Mlig455_018624, Mlig455_018810 | Neo: - Age: - |
CHRNA10, CHRNA7 | 1.872 | - | - | - | - | 0.976 | 0.896 | Mlig455_018624 {REF} {Length: 3606} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=2e-35]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=142, Expect=2e-35]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=1e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=1e-34]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=136, Expect=2e-33]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=145, Expect=2e-36]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=141, Expect=3e-35]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=140, Expect=2e-35]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=139, Expect=2e-34]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=142, Expect=2e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=3e-36]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=138, Expect=2e-34]} {RNA1509_9118} {RNA1310_65904} {RNA815_40596} Mlig455_018810 {REF} {Length: 2717} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=141, Expect=2e-35]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=2e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=139, Expect=2e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=139, Expect=2e-34]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=138, Expect=4e-34]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=145, Expect=2e-36]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=141, Expect=2e-35]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=140, Expect=8e-35]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=7e-35]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=142, Expect=1e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=4e-36]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=139, Expect=1e-34]} {RNA1509_9118} {RNA1310_84333} {RNA815_40596} |
53. | MligTC455_46170 | 9 | 0.19 | Mlig455_022412, Mlig455_047655, Mlig455_055613 | Neo: - Age: Up-Down-Down |
GTF2IRD2, GTF2IRD2B | 1.871 | - | - | - | - | 0.954 | 0.917 | Mlig455_022412 {REF} {Length: 3025} {Pfam: Domain of unknown function (DUF4371) [PF14291.8, score=38.5]; Spin-doc zinc-finger [PF18658.3, score=24.1]} {Human: ENSG00000174428, GTF2IRD2B, GTF2I repeat domain containing 2B, [RH, Score=393, Expect=3e-125]; ENSG00000196275, GTF2IRD2, GTF2I repeat domain containing 2, [RH, Score=390, Expect=2e-124]} {Mouse: ENSMUSG00000015942, Gtf2ird2, GTF2I repeat domain containing 2, [RH, Score=365, Expect=4e-115]} {Smed: dd_Smed_v6_25074_0_1, dd_Smed_v6_25074_0_1, [RH, Score=254, Expect=2e-76]} {RNA1509_50311} {RNA1310_1521.1, RNA1509_50311} {RNA1509_50311, RNA815_920.1} Mlig455_047655 {REF} {Length: 2123} {Pfam: Domain of unknown function (DUF4371) [PF14291.8, score=37.2]; Spin-doc zinc-finger [PF18658.3, score=24.1]} {Human: ENSG00000196275, GTF2IRD2, GTF2I repeat domain containing 2, [RH, Score=387, Expect=6e-123]; ENSG00000174428, GTF2IRD2B, GTF2I repeat domain containing 2B, [RH, Score=387, Expect=3e-123]} {Mouse: ENSMUSG00000015942, Gtf2ird2, GTF2I repeat domain containing 2, [RH, Score=360, Expect=4e-113]} {Smed: dd_Smed_v6_25074_0_1, dd_Smed_v6_25074_0_1, [RH, Score=256, Expect=3e-77]} {RNA1509_50311} {RNA1310_584.1} {RNA815_920.1} Mlig455_055613 {REF} {Length: 2267} {Pfam: Domain of unknown function (DUF4371) [PF14291.8, score=37.2]; Spin-doc zinc-finger [PF18658.3, score=24.1]} {Human: ENSG00000174428, GTF2IRD2B, GTF2I repeat domain containing 2B, [RH, Score=391, Expect=1e-124]; ENSG00000196275, GTF2IRD2, GTF2I repeat domain containing 2, [RH, Score=390, Expect=3e-124]} {Mouse: ENSMUSG00000015942, Gtf2ird2, GTF2I repeat domain containing 2, [RH, Score=364, Expect=2e-114]} {Smed: dd_Smed_v6_25074_0_1, dd_Smed_v6_25074_0_1, [RH, Score=255, Expect=6e-77]} {RNA1509_50311} {RNA1310_584.1} {RNA815_920.1} |
54. | MligTC455_11306 | 10 | 0.2 | Mlig455_030223 | Neo: - Age: - |
ANGPT4 | 1.87 | - | - | - | - | 0.966 | 0.904 | Mlig455_030223 {REF} {Length: 1102} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=82.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=75.5, Expect=4e-15]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=72.8, Expect=2e-14]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=71.6, Expect=6e-14]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=70.5, Expect=1e-13]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=68.9, Expect=6e-13]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=68.6, Expect=6e-13]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=68.6, Expect=7e-13]} {Dmel: FBgn0087011, CG41520, [Score=60.8, Expect=2e-10]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=7e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.6, Expect=6e-11]} {RNA1509_28467} {RNA1310_29813.1} {RNA815_57322} |
55. | MligTC455_37010 | 127 | 2.64 | Mlig455_012355 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.232/0.00085 |
1.87 | - | - | - | - | 0.906 | 0.964 | Mlig455_012355 {REF} {Length: 7737} {Pfam: HGWP repeat [PF03578.17, score=19.0]} {RNA1509_28298} {RNA1310_3268} {RNA815_628} | |
56. | MligTC455_41382 | 65 | 1.35 | Mlig455_022554 | Neo: - Age: - Region-enriched R2: 5.596/0.01432 |
1.869 | - | - | - | - | 0.968 | 0.901 | Mlig455_022554 {REF} {Length: 503} {Pfam: Pancreatic hormone peptide [PF00159.20, score=18.9]} {RNA1310_81495} {RNA815_42745} | |
57. | MligTC455_50123 | 29 | 0.61 | Mlig455_063710 | Neo: - Age: - Region-enriched R4: 5.673/0.02044 |
1.869 | - | - | - | - | 0.966 | 0.903 | Mlig455_063710 {REF} {Length: 1119} | |
58. | MligTC455_32164 | 149 | 3.11 | Mlig455_028109 | Neo: - Age: - |
1.868 | - | - | - | - | 0.905 | 0.963 | Mlig455_028109 {REF} {Length: 205} {NoTransDecoderORF} {RNA1310_31190} {RNA815_49804} | |
59. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
1.868 | - | - | - | - | 0.967 | 0.901 | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
60. | MligTC455_07976 | 9 | 0.19 | Mlig455_026945 | Neo: - Age: - |
1.867 | - | - | - | - | 0.966 | 0.901 | Mlig455_026945 {REF} {Length: 1312} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.6]} {RNA1310_34740} {RNA815_15663} | |
61. | MligTC455_14795 | 8 | 0.16 | Mlig455_001604 | Neo: - Age: - |
NPR1 | 1.867 | - | - | - | - | 0.966 | 0.901 | Mlig455_001604 {REF} {Length: 2245} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=181.5]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=251, Expect=3e-71]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=243, Expect=2e-68]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-70]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=244, Expect=1e-71]} {Dmel: FBgn0010197, Gyc32E, Guanyl cyclase at 32E, [Score=227, Expect=4e-63]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=224, Expect=2e-62]} {Smed: dd_Smed_v6_7644_0_1, dd_Smed_v6_7644_0_1, [Score=225, Expect=1e-62]} {RNA1310_77875} |
62. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
1.867 | - | - | - | - | 0.966 | 0.901 | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
63. | MligTC455_17299 | 538 | 11.21 | Mlig455_036559, Mlig455_057787 | Neo: - Age: - Region-enriched R2: 5.046/0.00000 |
1.867 | - | - | - | - | 0.964 | 0.903 | Mlig455_036559 {REF} {Length: 718} {RNA1509_57277} {RNA1310_52579, RNA1509_57277} {RNA1509_57277, RNA815_26706} Mlig455_057787 {REF} {Length: 741} {RNA1509_57277} {RNA1310_52579} {RNA815_26706} |
|
64. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 1.867 | - | - | - | - | 0.908 | 0.959 | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
65. | MligTC455_49769 | 11 | 0.23 | Mlig455_004340, Mlig455_004350 | Neo: - Age: Up-Down-Down |
ANOS1 | 1.867 | - | - | - | - | 0.966 | 0.901 | Mlig455_004340 {REF} {Length: 3275} {Pfam: Fibronectin type III domain [PF00041.23, score=59.5]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=114, Expect=6e-26]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=83.2, Expect=2e-16]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=86.3, Expect=3e-17]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=152, Expect=2e-38]} {RNA1509_44032} {RNA1310_20852} {RNA815_15013} Mlig455_004350 {REF} {Length: 3028} {Pfam: Fibronectin type III domain [PF00041.23, score=83.9]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=126, Expect=1e-29]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=85.9, Expect=4e-17]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=90.1, Expect=2e-18]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=183, Expect=3e-48]} {RNA1509_44032} {RNA1310_20852, RNA1509_44032} {RNA1509_44032, RNA815_15013} |
66. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
1.866 | - | - | - | - | 0.909 | 0.957 | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
67. | MligTC455_10966 | 15 | 0.31 | Mlig455_013154 | Neo: - Age: - |
1.865 | - | - | - | - | 0.966 | 0.899 | Mlig455_013154 {REF} {Length: 827} {Pfam: Lectin C-type domain [PF00059.23, score=21.8]} {RNA1509_20946} {RNA1310_65161} {RNA815_4785.1} | |
68. | MligTC455_53435 | 190 | 3.96 | Mlig455_045425, Mlig455_065748 | Neo: - Age: - Region-enriched R2: 4.111/0.00023 |
SYT9 | 1.865 | - | - | - | - | 0.899 | 0.966 | Mlig455_045425 {REF} {Length: 2615} {RNA1509_46689} {RNA1310_15031, RNA1509_46689} {RNA1509_46689, RNA815_18779.1} Mlig455_065748 {REF} {Length: 3143} {Pfam: C2 domain [PF00168.32, score=116.1]} {Human: ENSG00000170743, SYT9, synaptotagmin 9, [Score=162, Expect=4e-42]; ENSG00000213023, SYT3, synaptotagmin 3, [Score=157, Expect=5e-40]} {Mouse: ENSMUSG00000062542, Syt9, synaptotagmin IX, [Score=162, Expect=3e-42]; ENSMUSG00000030731, Syt3, synaptotagmin III, [Score=156, Expect=1e-39]} {Dmel: FBgn0261089, Sytalpha, Synaptotagmin alpha, [RH, Score=197, Expect=1e-54]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=144, Expect=8e-37]} {Smed: dd_Smed_v6_6730_0_1, dd_Smed_v6_6730_0_1, [Score=155, Expect=5e-41]} {RNA1509_46689} {RNA1310_15031} {RNA815_18779.1} |
69. | MligTC455_14830 | 177 | 3.68 | Mlig455_066372 | Neo: - Age: - |
SSUH2 | 1.864 | - | - | - | - | 0.884 | 0.980 | Mlig455_066372 {REF} {Length: 1569} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=184, Expect=2e-53]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=148, Expect=1e-40]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=119, Expect=2e-29]} {RNA1509_46058} {RNA1310_5028.1, RNA1509_46058} {RNA1509_46058, RNA815_5650} |
70. | MligTC455_32165 | 302 | 6.3 | Mlig455_028110, Mlig455_045231, Mlig455_069146 | Neo: - Age: - |
1.864 | - | - | - | - | 0.904 | 0.960 | Mlig455_028110 {REF} {Length: 668} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=31.4]; PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=19.9]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_31139.2} {RNA815_42018} Mlig455_045231 {REF} {Length: 2983} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=46.7]} {Smed: dd_Smed_v6_7982_0_1, dd_Smed_v6_7982_0_1, [RH, Score=115, Expect=4e-29]} {RNA1509_55345} {RNA1310_31139.1} {RNA815_42018} Mlig455_069146 {REF} {Length: 1639} {Pfam: PMP-22/EMP/MP20/Claudin family [PF00822.22, score=40.1]} {Smed: dd_Smed_v6_16515_0_1, dd_Smed_v6_16515_0_1, [RH, Score=99.0, Expect=7e-25]} {RNA1310_31190} {RNA815_42018} |
|
71. | MligTC455_24301 | 172 | 3.57 | Mlig455_029246 | Neo: - Age: - |
KCNQ5 | 1.861 | - | - | - | - | 0.899 | 0.962 | Mlig455_029246 {REF} {Length: 3519} {Pfam: KCNQ voltage-gated potassium channel [PF03520.16, score=122.6]; Ion transport protein [PF00520.33, score=99.3]; Ion channel [PF07885.18, score=51.1]; Putative sensor [PF13796.8, score=18.6]} {Human: ENSG00000185760, KCNQ5, potassium voltage-gated channel subfamily Q member 5, [RH, Score=477, Expect=9e-155]; ENSG00000117013, KCNQ4, potassium voltage-gated channel subfamily Q member 4, [RH, Score=459, Expect=3e-151]} {Mouse: ENSMUSG00000028033, Kcnq5, potassium voltage-gated channel, subfamily Q, member 5, [RH, Score=476, Expect=1e-154]} {Dmel: FBgn0033494, KCNQ, KCNQ potassium channel, [RH, Score=603, Expect=0.0]} {Celegans: WBGene00002233, kqt-1, KQT-1 potassium channel; Potassium channel, KvQLT family, [RH, Score=524, Expect=4e-176]} {Smed: dd_Smed_v6_12681_0_1, dd_Smed_v6_12681_0_1, [RH, Score=639, Expect=0.0]} {RNA1509_34272} {RNA1310_3730.1, RNA1509_34272} {RNA1509_34272, RNA815_2787} |
72. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 1.861 | - | - | - | - | 0.963 | 0.898 | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
73. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
1.861 | - | - | - | - | 0.951 | 0.910 | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
74. | MligTC455_10383 | 13 | 0.27 | Mlig455_040199 | Neo: - Age: - |
1.86 | - | - | - | - | 0.957 | 0.903 | Mlig455_040199 {REF} {Length: 860} {Pfam: Lectin C-type domain [PF00059.23, score=27.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
75. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
1.86 | - | - | - | - | 0.963 | 0.897 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
76. | MligTC455_12991 | 30 | 0.62 | Mlig455_037487 | Neo: - Age: - |
CHRNA6 | 1.859 | - | - | - | - | 0.958 | 0.901 | Mlig455_037487 {REF} {Length: 1592} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=70.8]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=55.6]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=119, Expect=5e-29]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=110, Expect=4e-26]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=109, Expect=3e-25]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=107, Expect=5e-25]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=107, Expect=8e-25]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=106, Expect=2e-24]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=111, Expect=4e-26]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=112, Expect=5e-27]} {RNA1310_100091} {RNA815_18433} |
77. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 1.859 | - | - | - | - | 0.898 | 0.961 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
78. | MligTC455_17895 | 389 | 8.1 | Mlig455_060774 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.268 Region-specific R2: 7.424 Region-enriched R2: 6.488/0.00062 Regeneration-downregulated R2: -4.133 Regeneration-depleted R2: -4.133 |
1.858 | - | - | - | - | 0.963 | 0.895 | Mlig455_060774 {REF} {Length: 1670} {RNA1509_34403} {RNA1310_35901, RNA1509_34403} {RNA1509_34403, RNA815_35590} | |
79. | MligTC455_53339 | 361 | 7.52 | Mlig455_044792, Mlig455_044816, Mlig455_055565 | Neo: - Age: - Region-enriched R2: 2.402/0.04439 |
DMBT1 | 1.858 | - | - | - | - | 0.888 | 0.970 | Mlig455_044792 {REF} {Length: 2555} {Pfam: Zona pellucida-like domain [PF00100.25, score=90.4]; Scavenger receptor cysteine-rich domain [PF00530.20, score=77.7]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=8e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=58.2, Expect=3e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.9, Expect=9e-14]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} Mlig455_044816 {REF} {Length: 2732} {Pfam: Zona pellucida-like domain [PF00100.25, score=89.0]; Scavenger receptor cysteine-rich domain [PF00530.20, score=78.1]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=9e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=8e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.6, Expect=1e-13]} {RNA1509_36885} {RNA1310_10008, RNA1509_36885} {RNA1509_36885, RNA815_6134} Mlig455_055565 {REF} {Length: 2284} {Pfam: Scavenger receptor cysteine-rich domain [PF00530.20, score=79.3]; Zona pellucida-like domain [PF00100.25, score=35.8]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=65.5, Expect=1e-10]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=4e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=55.1, Expect=4e-08]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} |
80. | MligTC455_14873 | 15 | 0.31 | Mlig455_021074 | Neo: - Age: - |
1.857 | - | - | - | - | 0.966 | 0.891 | Mlig455_021074 {REF} {Length: 1075} {Pfam: WSC domain [PF01822.21, score=52.6]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=46.6, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=50.8, Expect=2e-07]} {RNA1310_33352.1} {RNA815_14158.1} | |
81. | MligTC455_55986 | 9 | 0.2 | Mlig455_047193 | Neo: - Age: - |
1.857 | - | - | - | - | 0.959 | 0.898 | Mlig455_047193 {REF} {Length: 348} {NoTransDecoderORF} | |
82. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
1.855 | - | - | - | - | 0.954 | 0.901 | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
83. | MligTC455_15883 | 95 | 1.98 | Mlig455_020080, Mlig455_040893 | Neo: - Age: - |
1.855 | - | - | - | - | 0.897 | 0.958 | Mlig455_020080 {REF} {Length: 1487} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} Mlig455_040893 {REF} {Length: 1486} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=21.0]} {RNA1310_27849} {RNA815_37376} |
|
84. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.855 | - | - | - | - | 0.971 | 0.884 | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
85. | MligTC455_28575 | 27 | 0.55 | Mlig455_028366, Mlig455_052765 | Neo: - Age: - |
1.854 | - | - | - | - | 0.954 | 0.900 | Mlig455_028366 {REF} {Length: 771} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_22744} {RNA815_55880} Mlig455_052765 {REF} {Length: 1415} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_15798} {RNA1310_22744} {RNA815_55880} |
|
86. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
1.853 | - | - | - | - | 0.951 | 0.902 | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
87. | MligTC455_14307 | 7 | 0.14 | Mlig455_010232 | Neo: - Age: - |
1.852 | - | - | - | - | 0.962 | 0.890 | Mlig455_010232 {REF} {Length: 2384} {Pfam: Endonuclease-reverse transcriptase [PF14529.8, score=55.8]; Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=20.8]; PHD-finger [PF00628.31, score=19.7]} {RNA1310_115972} | |
88. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
1.852 | - | - | - | - | 0.968 | 0.884 | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
89. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
1.851 | - | - | - | - | 0.950 | 0.901 | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
90. | MligTC455_14872 | 28 | 0.58 | Mlig455_064004, Mlig455_064044 | Neo: - Age: logFC(26M/2M)=1.526 |
CLCA1 | 1.85 | - | - | - | - | 0.977 | 0.873 | Mlig455_064004 {REF} {Length: 4380} {Pfam: von Willebrand factor type A domain [PF00092.30, score=55.0]; von Willebrand factor type A domain [PF13768.8, score=48.2]; von Willebrand factor type A domain [PF13519.8, score=47.8]; vWA found in TerF C terminus [PF10138.11, score=29.1]; VWA domain containing CoxE-like protein [PF05762.16, score=28.0]; Calcium-activated chloride channel N terminal [PF08434.13, score=19.9]} {Human: ENSG00000016490, CLCA1, chloride channel accessory 1, [Score=150, Expect=1e-36]} {Mouse: ENSMUSG00000028255, Clca1, chloride channel accessory 1, [Score=154, Expect=6e-38]} {Smed: dd_Smed_v6_968_0_1, dd_Smed_v6_968_0_1, [Score=89.0, Expect=6e-18]} {RNA1509_43698} {RNA1310_4397} {RNA815_4081} Mlig455_064044 {REF} {Length: 4389} {Pfam: von Willebrand factor type A domain [PF00092.30, score=57.6]; von Willebrand factor type A domain [PF13768.8, score=50.7]; von Willebrand factor type A domain [PF13519.8, score=47.7]; vWA found in TerF C terminus [PF10138.11, score=29.0]; VWA domain containing CoxE-like protein [PF05762.16, score=26.0]; Calcium-activated chloride channel N terminal [PF08434.13, score=24.0]} {Human: ENSG00000016490, CLCA1, chloride channel accessory 1, [Score=157, Expect=9e-39]} {Mouse: ENSMUSG00000028255, Clca1, chloride channel accessory 1, [Score=159, Expect=2e-39]} {Smed: dd_Smed_v6_968_0_1, dd_Smed_v6_968_0_1, [Score=91.3, Expect=1e-18]} {RNA1509_43698} {RNA1310_4397, RNA1509_43698} {RNA1509_43698, RNA815_4081} |
91. | MligTC455_30160 | 55 | 1.15 | Mlig455_035128 | Neo: - Age: - Region-enriched R2: 5.270/0.01686 |
TCF7L1 | 1.85 | - | - | - | - | 0.964 | 0.886 | Mlig455_035128 {REF} {Length: 2946} {Pfam: HMG (high mobility group) box [PF00505.21, score=79.2]; HMG-box domain [PF09011.12, score=34.5]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=1e-42]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=7e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=2e-41]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=8e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=9e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=156, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=6e-48]} {RNA1509_46571} {RNA1310_11181} {RNA815_36690} |
92. | MligTC455_38355 | 110 | 2.29 | Mlig455_039715, Mlig455_039769 | Neo: - Age: - |
KCNB2 | 1.85 | - | - | - | - | 0.887 | 0.963 | Mlig455_039715 {REF} {Length: 3883} {Pfam: Ion transport protein [PF00520.33, score=114.4]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=218, Expect=3e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=213, Expect=2e-60]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=213, Expect=7e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=210, Expect=2e-59]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=7e-59]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=219, Expect=5e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=8e-61]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=213, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=8e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=236, Expect=3e-69]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} Mlig455_039769 {REF} {Length: 4176} {Pfam: Ion transport protein [PF00520.33, score=116.7]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]; Polycystin cation channel [PF08016.14, score=20.7]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=219, Expect=8e-61]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=216, Expect=2e-61]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=215, Expect=2e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=213, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=213, Expect=4e-60]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=210, Expect=4e-58]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=221, Expect=2e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=219, Expect=4e-61]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=216, Expect=6e-62]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=215, Expect=6e-61]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=211, Expect=1e-58]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=231, Expect=2e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=239, Expect=2e-70]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=595, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} |
93. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
1.849 | - | - | - | - | 0.953 | 0.896 | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
94. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
1.849 | - | - | - | - | 0.982 | 0.867 | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
95. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
1.849 | - | - | - | - | 0.871 | 0.978 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
96. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 1.849 | - | - | - | - | 0.887 | 0.962 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
97. | MligTC455_18100 | 17 | 0.36 | Mlig455_069127 | Neo: - Age: - |
PPA1 | 1.848 | - | - | - | - | 0.950 | 0.898 | Mlig455_069127 {REF} {Length: 2015} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1509_39915} {RNA1310_57333.1} {RNA815_22340} |
98. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 1.848 | - | - | - | - | 0.895 | 0.953 | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
99. | MligTC455_14363 | 57 | 1.18 | Mlig455_014133 | Neo: - Age: - Region-enriched R2: 4.499/0.01811 |
1.847 | - | - | - | - | 0.984 | 0.863 | Mlig455_014133 {REF} {Length: 323} {NoTransDecoderORF} | |
100. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 1.847 | - | - | - | - | 0.885 | 0.962 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |